Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc., 72895-72896 [2024-20082]
Download as PDF
<![CDATA[
72895
Federal Register / Vol. 89, No. 173 / Friday, September 6, 2024 / Notices
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 30, 2024, Bright
Green Corporation, 1033 George Hanosh
Boulevard, Grants, New Mexico 87020,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Marihuana Extract ....................................................................................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
The company plans to import tissue
culture that will be used to begin the
propagation of their bulk cannabis
manufacturing operation. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–20083 Filed 9–5–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1425]
Importer of Controlled Substances
Application: Biopharmaceutical
Research Company
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Biopharmaceutical Research
Company has applied to be registered as
an importer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 7, 2024. Such
persons may also file a written request
for a hearing on the application on or
before October 7, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
SUMMARY:
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 17, 2024,
Biopharmaceutical Research Company,
11045 Commercial Parkway, Castroville,
California 95012–3209, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
Drug code
lotter on DSK11XQN23PROD with NOTICES1
16:42 Sep 05, 2024
Jkt 262001
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–20085 Filed 9–5–24; 8:45 am]
BILLING CODE P
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
I
I
I
SUPPLEMENTARY INFORMATION:
Marihuana Extract ....................................................................................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
VerDate Sep<11>2014
7350
7360
7370
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
Controlled substance
The company plans to import
Marihuana Extract (7350), Marihuana
(7360) and Tetrahydrocannabinols
(7370) as flowering plants and cannabis
derivatives to support analytical
chemistry analyses, research and the
manufacturing of dosage forms for preclinical and clinical trials. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
Schedule
Schedule
7350
7360
7370
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1429]
Importer of Controlled Substances
Application: Cambridge Isotope
Laboratories, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
E:\FR\FM\06SEN1.SGM
06SEN1
I
I
I
72896
Federal Register / Vol. 89, No. 173 / Friday, September 6, 2024 / Notices
Cambridge Isotope
Laboratories, Inc. has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 7, 2024. Such
persons may also file a written request
for a hearing on the application on or
before October 7, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
SUMMARY:
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 24, 2024,
Cambridge Isotope Laboratories, Inc., 50
Frontage Road, Andover, Massachusetts
01810–5413, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Morphine ..................................................................................................................................................................
The company plans to import the
listed controlled substances for
preparation of analytical standards and
formulations. In reference to drug code
7370 (Tetrahydrocannabinols), the
company plans to import a synthetic
Tetrahydrocannabinol. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–20082 Filed 9–5–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
lotter on DSK11XQN23PROD with NOTICES1
Notice of Lodging of Proposed
Consent Decree Under the
Comprehensive Environmental
Response, Compensation and Liability
Act
On August 30, 2024, the Department
of Justice lodged a proposed consent
decree with the United States District
Court for the Southern District of Texas,
Corpus Christi Division, in the lawsuit
entitled United States v. Energy
Transfer (R&M), LLC, et al. Civil Action
No. 2:23–CV–214. The proposed
consent decree is between the United
VerDate Sep<11>2014
16:42 Sep 05, 2024
Jkt 262001
States and The Goodyear Tire & Rubber
Company (‘‘Goodyear’’).
The United States asserted claims in
this case under sections 107 and 113 of
the Comprehensive Environmental
Response, Compensation, and Liability
Act (‘‘CERCLA’’), 42 U.S.C. 9607 and
9613(g)(2), seeking to recover
unreimbursed response costs incurred
by the United States in responding to
releases of hazardous substances at the
Brine Service Company Inc. Superfund
Site (‘‘Site’’) in Corpus Christi, Nueces
County, Texas, and a declaratory
judgment for additional costs incurred
in performing further response actions
at the Site. Under the proposed Consent
Decree, Goodyear agrees to perform
cleanup activities in a portion of the
Site (called the ‘‘North Pit’’) and to pay
the United States’ future response costs
in connection with overseeing the work.
The United States will grant a covenant
not to sue or to take administrative
action against Goodyear pursuant to
sections 106 and 107 of CERCLA, 42
U.S.C. 9606 and 9607.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments on
the proposed Consent Decree should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States v. Energy Transfer (R&M),
LLC, et al., D.J. Ref. 90–11–3–10616/1.
All comments must be submitted no
later than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
PO 00000
Frm 00077
Fmt 4703
Sfmt 9990
Schedule
2010
7370
9300
I
I
II
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
Any comments submitted in writing
may be filed in whole or in part on the
public court docket without notice to
the commenter.
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
If you require assistance accessing the
consent decree, you may request
assistance by email or by mail to the
addresses provided above for submitting
comments.
Thomas Carroll,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2024–20099 Filed 9–5–24; 8:45 am]
BILLING CODE 4410–15–P
E:\FR\FM\06SEN1.SGM
06SEN1
]]>Agencies
[Federal Register Volume 89, Number 173 (Friday, September 6, 2024)]
[Notices]
[Pages 72895-72896]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20082]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1429]
Importer of Controlled Substances Application: Cambridge Isotope
Laboratories, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
[[Page 72896]]
SUMMARY: Cambridge Isotope Laboratories, Inc. has applied to be
registered as an importer of basic class(es) of controlled
substance(s). Refer to Supplementary Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
October 7, 2024. Such persons may also file a written request for a
hearing on the application on or before October 7, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 24, 2024, Cambridge Isotope Laboratories, Inc.,
50 Frontage Road, Andover, Massachusetts 01810-5413, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............... 2010 I
Tetrahydrocannabinols................... 7370 I
Morphine................................ 9300 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
preparation of analytical standards and formulations. In reference to
drug code 7370 (Tetrahydrocannabinols), the company plans to import a
synthetic Tetrahydrocannabinol. No other activities for these drug
codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-20082 Filed 9-5-24; 8:45 am]
BILLING CODE P
